Efficacy of Eribulin Monotherapy in Patients with Unresectable Angiosarcoma--A Multicenter Prospective Observational Study
Not Applicable
- Conditions
- Angiosarcoma
- Registration Number
- JPRN-UMIN000023331
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Primary endpoint:OS
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe bone marrow suppression 2) Presence of uncontrolled hemopneumothorax 3) Pregnancy or possibility of pregnancy 4) Investigator's decision
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Secondary endpoint:response ratio, PFS, adverse events